Patricia Oyetakin
Dermatology · Atlanta, GANPI 1740592575
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.5% of the total across 208 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 12.3% — the pattern of someone who eats at a lot of different presentations.
Across 208 payments — averaging $26.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$669
- Regeneron Healthcare Solutions, Inc.$601
- Johnson & Johnson$472
- E.r. Squibb & Sons, L.L.C.$467
- UCB, Inc.$363
- Arcutis Biotherapeutics, Inc.$263
- plus $3K from 26 others
What the payments were for
- Food & beverage$4,99392%
- Education$4628%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 34 | $669 |
| Regeneron Healthcare Solutions, Inc. | 20 | $601 |
| Johnson & Johnson | 15 | $472 |
| E.r. Squibb & Sons, L.L.C. | 21 | $467 |
| UCB, Inc. | 10 | $363 |
| Arcutis Biotherapeutics, Inc. | 9 | $263 |
| LEO Pharma Inc. | 7 | $261 |
| Organon | 5 | $193 |
| Novartis | 10 | $191 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $182 |
| Boehringer Ingelheim | 8 | $171 |
| Lilly USA, LLC | 11 | $169 |
| Incyte Corporation | 7 | $152 |
| Dermavant Sciences, Inc. | 2 | $146 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 6 | $124 |
| Sanofi | 5 | $120 |
| Galderma Laboratories, L.p. | 5 | $108 |
| Eli Lilly | 1 | $99 |
| Paratek Pharmaceuticals, Inc. | 4 | $84 |
| Mayne Pharma Commercial LLC | 3 | $75 |
| Sun Pharmaceutical Industries Inc. | 4 | $74 |
| Amgen | 3 | $70 |
| Almirall LLC | 2 | $65 |
| Octapharma USA, Inc. | 3 | $61 |
| Mallinckrodt Hospital Products Inc. | 2 | $55 |
| Pfizer | 2 | $43 |
| Helsinn Therapeutics (U.S.), Inc. | 2 | $42 |
| Sandoz | 2 | $41 |
| Blueprint Medicines Corporation | 1 | $30 |
| Botanix SB Inc | 1 | $27 |
| Verrica Pharmaceuticals Inc. | 1 | $21 |
| Krystal Biotech Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,455 in reported general payments places this provider in the 55th percentile of 345 dermatology providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 24 | $150,079 |
| Clobetasol Propionate | 32 | $1,457 |
| Tacrolimus | 14 | $1,454 |
| Doxycycline Hyclate | 22 | $508 |
| Ketoconazole | 17 | $332 |
| Minoxidil | 36 | $220 |
| MethotrexateMethotrexate Sodium | 13 | $114 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Atlanta
- Zakiya RiceAtlanta$1.1M
- Joseph PayneAtlanta$711K
- Jamie WeismanAtlanta$620K
- Mack RachalAtlanta$260K
- Sumayah TaliaferroAtlanta$104K
- Sarah ChisolmAtlanta$59K
- Anna PareAtlanta$58K
- Lauren OrensteinAtlanta$52K
- Chelsie RogersAtlanta$43K
- Ron FeldmanAtlanta$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.